Underexpression of p27/Kip in thyroid papillary microcarcinomas with gross metastatic disease

Archives of Otolaryngology - Head and Neck Surgery

Volumn 128, Issue 3, 2002, Pages 253-257

  Khoo, Mark L C ^a   Freeman, Jeremy L ^a   Witterick, Ian J ^a   Irish, Jonathan C ^a   Rotstein, Lorne E ^a   Gullane, Patrick J ^a   Asa, Sylvia L ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P27;

ADULT; AGED; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; GENE EXPRESSION REGULATION; GENE MUTATION; GENE OVEREXPRESSION; GENE REARRANGEMENT; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MALE; THYROID PAPILLARY CARCINOMA; THYROID SURGERY; TUMOR SUPPRESSOR GENE;

EID: 0036120668     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.128.3.253     Document Type: Conference Paper

References (25)

1. Occult papillary carcinoma of the thyroid
2. Occult micropapillary carcinoma associated with benign follicular thyroid disease and unrelated thyroid neoplasms
3. Clinicopathologic and immunohistochemical studies of papillary thyroid microcarcinoma presenting with cervical lymphadenopathy
4. RET/PTC oncogene activation is an early event in thyroid carcinogenesis
5. Immunohistochemical localization of p53 in human thyroid neoplasms: Correlation with biological behavior
6. Stepwise participation of p53 gene mutation during dedifferentiation of human thyroid carcinomas
7. Distinct multiple RET/PTC gene rearrangements in multifocal papillary thyroid neoplasia
8. ret/PTC expression may be associated with local invasion of thyroid papillary carcinoma
9. Sporadic retrearranged papillary carcinoma of the thyroid: A subset of slow growing, less aggressive thyroid neoplasms?
10. RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes
11. Overexpression of p53 in tall-cell variants of papillary thyroid carcinoma
12. Co-overexpression of p53 protein and epidermal growth factor receptor in human papillary thyroid carcinomas correlated with lymph node metastases, tumor size and clinicopathologic stage
13. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors
14. Downregulation of p27Kip1 and Ki-67/Mib1 labeling index support the classification of thyroid carcinoma into prognostically relevant categories
15. Anaplastic transformation of papillary thyroid carcinoma in recurrent disease in regional lymph nodes: A histologic and immunohistochemical study
16. Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases
17. Reduced expression of cyclindependent kinase inhibitor p27Kip1 is associated with advanced stage and invasiveness of gastric carcinomas
18. Reduced expression of the cell-cycle Inhibitor p27Kip1 is associated with progression and lymph node metastases of gastric carcinoma
19. Prognostic role of p27Kip1 and apoptosis in human breast cancer
20. Expression of p27kip1 in prostatic adenocarcinoma
21. Reduced expression of p27(Kip1) protein in relation to salivary adenoid cystic carcinoma metastasis
22. Aberrant p27kip1 expression in endocrine and other tumors
23. p27kip1 expression distinguishes papillary hyperplasia in Graves' disease from papillary thyroid carcinoma
24. The role of cell cycle regulatory proteins, cyclin D1, cyclin E, and p27 in thyroid carcinogenesis
25. Immunohistochemical analysis of p27/kip1 expression in thyroid carcinoma